VM Vivani Medical, Inc. Stock: price and directors' dealings · United States · SEC (Form 4)Track the Vivani Medical, Inc. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Market capitalisation: €130.8m. The latest transaction was filed on 16 July 2026 (Acquisition). Among the most active insiders: Williams Gregg. Every trade is free.
Analyst consensus: bullish or bearish? Analysts rate Vivani Medical, Inc. Strong Buy (bullish), based on 3 analysts. Average price target: US$3.83.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 16 July 2026
All Executives94 Thresholds0 Prospectus0 Other0
Declarations 94 total
▲ Director · Executives · 15 Jul 2026
793,650 shares @ US$1.26 0.82% mcap 3.6% of flow Common Stock SEC:0001753926-26-001192:0
Canonical exit: 13 Oct 2026 (T+90) ▲ Director · Executives · 15 Apr 2026
1,587,301 shares @ US$1.26 1.51% mcap 24.2% of flow Common Stock SEC:0001753926-26-000672:0
Canonical exit: 14 Jul 2026 (T+90) ▲ Director · Executives · 15 Mar 2026
1,310,680 shares @ US$1.03 14.3% of flow Common Stock SEC:0001753926-26-000475:0
Canonical exit: 13 Jun 2026 (T+90) ▲ Director · Executives · 15 Feb 2026
1,601,941 shares @ US$1.03 5.9% of flow Common Stock SEC:0001753926-26-000323:0
Canonical exit: 16 May 2026 (T+90) ▲ Director · Executives · 27 Jan 2026
1,351,351 shares @ US$1.48 7.2% of flow Common Stock SEC:0001753926-26-000196:0
Canonical exit: 27 Apr 2026 (T+90) ▲ Director · Executives · 15 Jan 2026
1,473,214 shares @ US$1.12 6.0% of flow Common Stock SEC:0001753926-26-000145:0
Canonical exit: 15 Apr 2026 (T+90) ● Director · Executives · 8 Jul 2024
20,000 shares 0Common Stock SEC:0001753926-25-002003:0
▲ Director · Executives · 15 Dec 2025
1,473,214 shares @ US$1.12 7.4% of flow Common Stock SEC:0001753926-25-001892:0
Canonical exit: 15 Mar 2026 (T+90) ▲ Director · Executives · 15 Nov 2025
1,473,214 shares @ US$1.12 8.1% of flow Common Stock SEC:0001753926-25-001808:0
Canonical exit: 13 Feb 2026 (T+90) ▲ Director · Executives · 27 Oct 2025
3,703,703 shares @ US$1.62 31.9% of flow Common Stock SEC:0001753926-25-001658:0
Canonical exit: 25 Jan 2026 (T+90) ▲ Director · Executives · 15 Oct 2025
1,473,214 shares @ US$1.12 12.9% of flow Common Stock SEC:0001753926-25-001616:0
Canonical exit: 13 Jan 2026 (T+90) ▲ Director · Executives · 15 Sept 2025
1,473,215 shares @ US$1.12 14.6% of flow Common Stock SEC:0001753926-25-001511:0
Canonical exit: 14 Dec 2025 (T+90) ▲ Director · Executives · 14 May 2025
3,499 shares @ US$1.01 0.1% of flow Common Stock SEC:0001753926-25-000860:0
Canonical exit: 12 Aug 2025 (T+90) ▲ Director · Executives · 24 Apr 2025
1,113 shares @ US$1.01 0.0% of flow Common Stock SEC:0001554855-25-000391:0
Canonical exit: 23 Jul 2025 (T+90) ▲ Director · Executives · 21 Apr 2025
1,569 shares @ US$1.01 0.0% of flow Common Stock SEC:0001753926-25-000675:0
Canonical exit: 20 Jul 2025 (T+90) ▲ Director · Executives · 9 Apr 2025
18,529 shares @ US$1.02 0.3% of flow Common Stock SEC:0001753926-25-000620:0
Canonical exit: 8 Jul 2025 (T+90) ▲ Director · Executives · 4 Apr 2025
34,000 shares @ US$0.99 0.6% of flow Common Stock SEC:0001753926-25-000596:0
Canonical exit: 3 Jul 2025 (T+90) ▲ Director · Executives · 2 Apr 2025
2,000 shares @ US$1.01 0.0% of flow Common Stock SEC:0001753926-25-000583:0
Canonical exit: 1 Jul 2025 (T+90) ▲ Chief Business Officer · Executives · 1 Apr 2025
4,000 shares @ US$1.025 8.8% of flow Common Stock SEC:0001753926-25-000555:0
Canonical exit: 30 Jun 2025 (T+90) ▲ Chief Business Officer · Executives · 28 Feb 2025
1,000 shares @ US$1.11 2.5% of flow Common Stock SEC:0001753926-25-000392:0
Canonical exit: 29 May 2025 (T+90) ▲ Director · Executives · 8 Nov 2024
3,968,253 shares @ US$1.26 87.2% of flow Common Stock SEC:0001753926-24-001875:0
Canonical exit: 6 Feb 2025 (T+90) ▲ Chief Business Officer · Executives · 1 Oct 2024
1,000 shares @ US$1.14 2.4% of flow Common Stock SEC:0001753926-24-001643:0
Canonical exit: 30 Dec 2024 (T+90) ▲ Chief Business Officer · Executives · 30 Jul 2024
5,000 shares @ US$1.24 13.2% of flow Common Stock SEC:0001753926-24-001335:0
Canonical exit: 28 Oct 2024 (T+90) ▲ Chief Business Officer · Executives · 22 Nov 2023
2,000 shares @ US$0.96 4.1% of flow Common Stock SEC:0001753926-24-001334:0
Canonical exit: 20 Feb 2024 (T+90) ▲ Director · Executives · 15 Feb 2024
1,078 shares @ US$1.01 0.0% of flow Common Stock SEC:0001753926-24-000345:0
Canonical exit: 15 May 2024 (T+90) 25 of 94 declarations
Load more (69 remaining) About Vivani Medical, Inc. Vivani Medical, Inc. is a company focused on developing innovative medical devices. It specializes in solutions for the treatment of chronic diseases.